DrugDashboards

pitavastatin calcium

pitavastatin calcium · PITAVASTATIN CALCIUM 2 mg/1 · Tablet, Film Coated · Oral · XLCare Pharmaceuticals Inc.

NDC 72865-0292-90 · 90 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for pitavastatin calcium (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA205977
TE code
AB
Approval date
Apr 30, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of pitavastatin calcium (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
AvKAREPITAVASTATIN CALCIUM 4.18 mg/1Jul 15, 2026Sep 2, 2026
AvKAREPITAVASTATIN CALCIUM 1.045 mg/1Jul 15, 2026Sep 2, 2026
AvKAREPITAVASTATIN CALCIUM 2.09 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 1.045 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 4.18 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 2.09 mg/1Jul 15, 2026Sep 2, 2026
Kowa Pharmaceuticals America, Inc.PITAVASTATIN CALCIUM 4.18 mg/1Jul 15, 2026Sep 2, 2026
Kowa Pharmaceuticals America, Inc.PITAVASTATIN CALCIUM 2.09 mg/1Jul 15, 2026Sep 2, 2026
Kowa Pharmaceuticals America, Inc.PITAVASTATIN CALCIUM 1.045 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCPITAVASTATIN CALCIUM 2.09 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCPITAVASTATIN CALCIUM 4.18 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 4.18 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 1.045 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.PITAVASTATIN CALCIUM 2.09 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals Inc.PITAVASTATIN CALCIUM 4 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals Inc.PITAVASTATIN CALCIUM 2 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals Inc.PITAVASTATIN CALCIUM 1 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "pitavastatin calcium — NDC 72865-0292-90," retrieved September 3, 2026, https://drugdashboards.com/drug/72865029290.

Free to cite with attribution — see how the data is put together.